PNC
HALO icon

Point Nemo Capital’s Halozyme HALO Stock Holding History

Point Nemo Capital’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$939 Buy
+12
New +$818 ﹤0.01% 174
2026
Q1 		– Sell
-10,267
Closed -$691K – 102
2025
Q4 		$691K Buy
+10,267
New +$691K 0.68% 69

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Point Nemo Capital's HALO Position: Q2 2026 in Review

Point Nemo Capital opened a new position in Halozyme (HALO) in Q2 2026: 12 shares worth $939. The stake represents ﹤0.01% of the portfolio and ranks #174 among its holdings. This is a return to the name: Point Nemo Capital previously reported a position in HALO as recently as Q4 2025.

Point Nemo Capital first reported a position in HALO in Q4 2025 and has held it in 2 quarters since. The position peaked at $691K in Q4 2025. 629 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Point Nemo Capital held 12 shares of Halozyme worth $939 as of Q2 2026.
  • Halozyme was a new Point Nemo Capital position in Q2 2026.
  • Halozyme made up ﹤0.01% of Point Nemo Capital's portfolio in Q2 2026, its #174 holding.
  • Point Nemo Capital first reported a position in Halozyme in Q4 2025 and has held it in 2 quarters since.
  • Point Nemo Capital's Halozyme position peaked at $691K in Q4 2025.
  • 629 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Point Nemo Capital's 13F filing for Q2 2026, filed 7 Aug 2026.